VVEO3.SA- CM Hospitalar S/A
🇧🇷 BRLHealthcare · Medical Distribution
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
Wall Street consensus from 5 analysts
12-Month Price Target
$1.22
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $0.81
Graham Number
√(22.5 × EPS × Book Value)
$4.83
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$4.54
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
5/10
63% score
Pays dividends
5Y hist.5+ years of dividend history
Dividend consistency (5Y+)
5 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
3.2%Return on equity - measures how efficiently capital is used
Positive profit margin
0.5%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+3.4%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
209.74×Low financial leverage reduces risk of distress
Current ratio above 1
1.72×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$908K/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
EPS (TTM)
$0.18
P/E (TTM)
4.5
Fwd P/E
-86.9
Dividends & Income
Dividends
Current DY
-
5Y Avg Annual
$0.1635
Last Payment
$0.1365
Ex-Date
05/02/2024
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest05/02/2024 | 05/16/2024 | $0.1365 | 67.42% |
12/27/2022 | 01/10/2023 | $0.2760 | 136.30% |
05/02/2022 | 05/16/2022 | $0.1570 | 77.51% |
12/29/2021 | 01/12/2022 | $0.2478 | 122.39% |
Magic Number
Shares needed to self-fund your next purchase
$0.81
Price
$0.1365
Last div. (yearly)
6
shares
Own 6 VVEO3.SA shares ($4.86) and each yearly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$4.86
New shares / year
+1 shares
Dividend Calculator
100.90% yieldEstimate VVEO3.SA dividend income at the current rate.
Per year
$10,090.4
Per month
$840.87
≈ 12,345.7 shares at $0.82/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
VVEO3.SA vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
R$ 552.068,46
Total invested
R$ 130.000,00
Total interest
R$ 422.068,46
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | R$ 10.000,00 | R$ 10.000,00 | R$ 0,00 |
| Year 1 | R$ 17.523,25 | R$ 16.000,00 | R$ 1.523,25 |
| Year 2 | R$ 25.949,29 | R$ 22.000,00 | R$ 3.949,29 |
| Year 3 | R$ 35.386,45 | R$ 28.000,00 | R$ 7.386,45 |
| Year 4 | R$ 45.956,07 | R$ 34.000,00 | R$ 11.956,07 |
| Year 5 | R$ 57.794,05 | R$ 40.000,00 | R$ 17.794,05 |
| Year 6 | R$ 71.052,59 | R$ 46.000,00 | R$ 25.052,59 |
| Year 7 | R$ 85.902,15 | R$ 52.000,00 | R$ 33.902,15 |
| Year 8 | R$ 102.533,65 | R$ 58.000,00 | R$ 44.533,65 |
| Year 9 | R$ 121.160,94 | R$ 64.000,00 | R$ 57.160,94 |
| Year 10 | R$ 142.023,50 | R$ 70.000,00 | R$ 72.023,50 |
| Year 11 | R$ 165.389,57 | R$ 76.000,00 | R$ 89.389,57 |
| Year 12 | R$ 191.559,57 | R$ 82.000,00 | R$ 109.559,57 |
| Year 13 | R$ 220.869,97 | R$ 88.000,00 | R$ 132.869,97 |
| Year 14 | R$ 253.697,61 | R$ 94.000,00 | R$ 159.697,61 |
| Year 15 | R$ 290.464,57 | R$ 100.000,00 | R$ 190.464,57 |
| Year 16 | R$ 331.643,57 | R$ 106.000,00 | R$ 225.643,57 |
| Year 17 | R$ 377.764,05 | R$ 112.000,00 | R$ 265.764,05 |
| Year 18 | R$ 429.418,98 | R$ 118.000,00 | R$ 311.418,98 |
| Year 19 | R$ 487.272,51 | R$ 124.000,00 | R$ 363.272,51 |
| Year 20 | R$ 552.068,46 | R$ 130.000,00 | R$ 422.068,46 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The Ibovespa, Brazil's main stock index, has historically returned roughly 12%/year in nominal terms over long periods. The CDI, the interbank interest benchmark, sits around 11% and tracks the Selic rate. The poupança (savings) pays about 6%, while inflation (IPCA) has run near 5%. Nominal Brazilian returns look high next to US figures mainly because inflation is higher, so compare real (inflation-adjusted) returns when planning.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Get the weekly market breakdown
Real numbers, plain English, no hype. The stories and data that actually move stocks and crypto, straight to your inbox.
Subscribe freeDiscussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About CM Hospitalar S/A
CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers material products for cardiac, surgical, urinary, diagnosis, sterilization, wound management, hygiene and protection, infusion, clinical nutrition, orthopedic, and respiratory; and medications, such as painkillers, anesthetics, anti-allergy, antibiotics, antiemetics, antifungals, anti-inflammatory, special control, several, and oncology. It also provides materials for respiratory assistance, therapy, anti-inflammatories, anti-tnf, antacid, antiandrogens, antianemics, anti-asthmatics, antibiotics, anticoagulant, anticonvulsant, monoclonal antibody, anti-growth, antidepressants, antidiabetic drug, antidiuretics, antidote, antiemetics and antinauseants, anti-migraine, antiepileptics, antiestrogens, antifibrinolytics, antiflatulents, antifungals, antihemorrhagic drug, antimicrobial, antineoplastics, antiparathyroid, antiparkinsonian, antipsychotics, systemic antipsoriasis, antirheumatic drugs, anti-varicose, antivirals, beta-blockers, carbohydrate, cycloplegic, contraceptives, contrast, special control, corticosteroids, topical debriding agent, diuretics, several, electrolyte, pancreatic enzyme, erythropoietins, uterine stimulant, cardiac stimulators, growth factor, granulocyte colony stimulating factor, gastroprokinetics, systemic hemostatics, heparins, hepatoprotective and lipotropic agents, hormone, adenohypophyseal hormones, growth hormones, immunoglobulins, immunosuppressants, labor induction drugs, proton pump inhibitor, phosphodiesterase and bone resorption inhibitor, platelet aggregation inhibitors, adenosine diphosphate receptor antagonists, proton pump inhibitors, interleukin inhibitors, subtilisin/kexin type 9 proprotein convertase inhibitors, calcium reabsorption inhibitors, materials, medications, nutrition, therapy, orthopedic therapy. CM Hospitalar S/A was incorporated in 2010 and is headquartered in São Paulo, Brazil.
Sector
Healthcare
Industry
Medical Distribution
Location
São Paulo, Brazil
Employees
6,000
CEO
André Clark Juliano
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
CM Hospitalar S/A (VVEO3.SA) stock trades at $0.81, up 5.19% on the day. With a market capitalization of $256 million, VVEO3.SA is a micro-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 4.5 and earnings per share (EPS) of $0.18. Over the most recent period the company reported 3% year-over-year revenue growth and a net profit margin of 0.5%. Below you'll find VVEO3.SA's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
VVEO3.SA - Frequently Asked Questions
Is CM Hospitalar S/A (VVEO3.SA) a good stock to buy in 2026?
CM Hospitalar S/A (VVEO3.SA) shows risks such as high leverage (debt/equity of 209.7). Whether VVEO3.SA is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is VVEO3.SA's stock price today?
CM Hospitalar S/A (VVEO3.SA) trades at $0.81 as of October 2, 2026, up 5.19% on the session. Prices on this page update throughout the trading day.
Does VVEO3.SA pay a dividend?
No. CM Hospitalar S/A (VVEO3.SA) does not currently pay a dividend, so the return comes entirely from share-price appreciation.
Is VVEO3.SA overvalued?
With a P/E ratio of 4.5×, VVEO3.SA trades at a relatively modest valuation for the healthcare sector. See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is VVEO3.SA's market cap?
CM Hospitalar S/A (VVEO3.SA) has a market capitalization of $256 million, classifying it as a micro-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.